1. Associations and prognostic implications of Eastern Cooperative Oncology Group performance status and tumoral LINE-1 methylation status in stage III colon cancer patients. Issue 1 (December 2016) Authors: Chen, Duo; Wen, Xianyu; Song, Young; Rhee, Ye-Young; Lee, Tae; Cho, Nam; Han, Sae-Won; Kim, Tae-You; Kang, Gyeong Journal: Clinical epigenetics Issue: Volume 8:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma. Issue 1 (December 2015) Authors: Lee, Kyung-Hun; Lee, Kyoung-Bun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Yi, Nam-Joon; Lee, Kwang-Woong; Suh, Kyung-Suk; Jang, Ja-June; Bang, Yung-Jue Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells. Issue 1 (December 2015) Authors: Min, Ahrum; Im, Seock-Ah; Kim, Debora; Song, Sang-Hyun; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Kim, Tae-You; O'Connor, Mark; Bang, Yung-Jue Journal: Breast cancer research Issue: Volume 17:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Metabolic Characteristics of Advanced Biliary Tract Cancer Using 18F-Fluorodeoxyglucose Positron Emission Tomography and Their Clinical Implications. (22nd June 2015) Authors: Cho, Kyoung-Min; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Journal: Oncologist Issue: Volume 20:Number 8(2015) Page Start: 926 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial. Issue 10088 (24th June 2017) Authors: El-Khoueiry, Anthony B; Sangro, Bruno; Yau, Thomas; Crocenzi, Todd S; Kudo, Masatoshi; Hsu, Chiun; Kim, Tae-You; Choo, Su-Pin; Trojan, Jörg; Welling, Theodore H; Meyer, Tim; Kang, Yoon-Koo; Yeo, Winnie; Chopra, Akhil; Anderson, Jeffrey; dela Cruz, Christine; Lang, Lixin; Neely, Jaclyn; Tang, Hao;... Journal: Lancet Issue: Volume 389:Issue 10088(2017) Page Start: 2492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10-year follow-up of an open-label, non-inferiority, randomised controlled trial. (July 2021) Authors: Park, Ji Won; Kang, Sung-Bum; Hao, Jie; Lim, Seok-Byung; Choi, Hyo Seong; Kim, Duck-Woo; Chang, Hee Jin; Kim, Dae Yong; Jung, Kyung Hae; Kim, Tae-You; Kang, Gyeong Hoon; Chie, Eui Kyu; Kim, Sun Young; Sohn, Dae Kyung; Kim, Jae-Sung; Lee, Hye Seung; Kim, Jee Hyun; Jeong, Seung-Yong; Oh, Jae Hwan Journal: Lancet gastroenterology and hepatology Issue: Volume 6:Number 7(2021) Page Start: 569 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial. Issue 7 (July 2021) Authors: Galle, Peter R; Finn, Richard S; Qin, Shukui; Ikeda, Masafumi; Zhu, Andrew X; Kim, Tae-You; Kudo, Masatoshi; Breder, Valeriy; Merle, Philippe; Kaseb, Ahmed; Li, Daneng; Mulla, Sohail; Verret, Wendy; Xu, Derek-Zhen; Hernandez, Sairy; Ding, Beiying; Liu, Juan; Huang, Chen; Lim, Ho Yeong; Cheng, Ann... Journal: Lancet oncology Issue: Volume 22:Issue 7(2021) Page Start: 991 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prognostic Impact of Extramural Lymphatic, Vascular, and Perineural Invasion in Stage II Colon Cancer: A Comparison With Intramural Invasion. Issue 3 (23rd March 2022) Authors: Cho, Sang Sik; Park, Ji Won; Kang, Gyeong Hoon; Kim, Jung Ho; Bae, Jeong Mo; Han, Sae-Won; Kim, Tae-You; Kim, Min Jung; Ryoo, Seung-Bum; Jeong, Seung-Yong; Park, Kyu Joo Journal: Diseases of the colon & rectum Issue: Volume 66:Issue 3(2023) Page Start: 366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients. Issue 1 (December 2015) Authors: Lee, Dae-Won; Han, Sae-Won; Cha, Yongjun; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Park, Ji; Ryoo, Seung-Bum; Jeong, Seung-Yong; Kang, Gyeong; Park, Kyu; Kim, Tae-You Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prognostic Role of Body Mass Index in Advanced Small Bowel Adenocarcinoma Patients Receiving Palliative Chemotherapy. (3rd July 2016) Authors: Lee, Dae-Won; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Journal: Nutrition and cancer Issue: Volume 68:Number 5(2016) Page Start: 750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗